Merimepodib
Merimepodib (VX-497) is a potent, non-competitive inhibitor of the enzyme IMPDH, a key target in nucleotide biosynthesis. It has been utilized in research exploring antiviral and immunosuppressive mechanisms, with studies conducted both in vitro and in animal models of autoimmune and inflammatory diseases.
Product Specifications
CAS Number
198821-22-6
Product Name Alternative
Merimepodib, HBV, HCV, HCV Protease, HCVProtease, Hepatitis B virus, Hepatitis C virus, inhibit, Inhibitor, IMPDH, MMPD, Antiviral, VI21497, VI-21497, VI 21497, VX 497, VX497, VX-497
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Metabolism Research, Protein Biochemistry
Purity
98.77% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.42 mM) ; DMSO:235 mg/mL (519.38 mM)
Smiles
COc1cc (NC (=O) Nc2cccc (CNC (=O) O[C@H]3CCOC3) c2) ccc1-c1cnco1
Molecular Formula
C23H24N4O6
Molecular Weight
452.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
248024-FITC 100 µL
KRT23 (Keratin 23 (Histone Deacetylase Inducible), CK23, DKFZp434G032, HAIK1, K23, MGC26158) (FITC)
Sign In for Pricing
View Details 
GTR15177401 1 Vial
Lentiviral mouse Popdc2 shRNA (UAS) - Lentiviral mouse Popdc2 shRNA (UAS) (25)
Sign In for Pricing
View Details